These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23997051)

  • 21. Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension.
    Akagi S; Matsubara H; Nakamura K; Ito H
    J Cardiol; 2018 Dec; 72(6):466-472. PubMed ID: 29898864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary arterial hypertension: pharmacologic therapies and potential pulmonary artery denervation treatment.
    Zhang YJ; Li MH; Chen SL
    EuroIntervention; 2013 May; 9 Suppl R():R149-54. PubMed ID: 23732148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New horizons in pulmonary arterial hypertension therapies.
    Galiè N; Ghofrani AH
    Eur Respir Rev; 2013 Dec; 22(130):503-14. PubMed ID: 24293466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Arterial Hypertension in Women.
    Memon HA; Park MH
    Methodist Debakey Cardiovasc J; 2017; 13(4):224-237. PubMed ID: 29744015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse effects of benfluorex on heart valves and pulmonary circulation.
    Szymanski C; Andréjak M; Peltier M; Maréchaux S; Tribouilloy C
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):679-86. PubMed ID: 24817577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension.
    Narechania S; Torbic H; Tonelli AR
    J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):131-141. PubMed ID: 31594400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
    Mohamed NA; Ahmetaj-Shala B; Duluc L; Mackenzie LS; Kirkby NS; Reed DM; Lickiss PD; Davies RP; Freeman GR; Wojciak-Stothard B; Chester AH; El-Sherbiny IM; Mitchell JA; Yacoub MH
    J Cardiovasc Transl Res; 2016 Apr; 9(2):162-4. PubMed ID: 26960567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.
    Weatherald J; Chaumais MC; Montani D
    Curr Opin Pulm Med; 2017 Sep; 23(5):392-397. PubMed ID: 28639957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
    Weir EK; Reeve HL; Huang JM; Michelakis E; Nelson DP; Hampl V; Archer SL
    Circulation; 1996 Nov; 94(9):2216-20. PubMed ID: 8901674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
    Hlavaty A; Roustit M; Montani D; Chaumais MC; Guignabert C; Humbert M; Cracowski JL; Khouri C
    Br J Clin Pharmacol; 2022 Dec; 88(12):5227-5237. PubMed ID: 35679331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
    Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary arterial hypertension: the burden of disease and impact on quality of life.
    Delcroix M; Howard L
    Eur Respir Rev; 2015 Dec; 24(138):621-9. PubMed ID: 26621976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
    Godinas L; Guignabert C; Seferian A; Perros F; Bergot E; Sibille Y; Humbert M; Montani D
    Semin Respir Crit Care Med; 2013 Oct; 34(5):714-24. PubMed ID: 24037637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management.
    Correale M; Tricarico L; Grazioli D; Formica ES; Petrucci R; Persichella P; Di Biase M; Brunetti ND
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):725-738. PubMed ID: 31811420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macitentan for the treatment of pulmonary arterial hypertension.
    Spikes L; Williamson T; Satterwhite L
    Drugs Today (Barc); 2014 Jun; 50(6):401-6. PubMed ID: 24983588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.